Alexander Swarbrick Selected Research

Alexander Swarbrick Research Topics

Disease

41	Neoplasms (Cancer) 04/2024 - 06/2002
33	Breast Neoplasms (Breast Cancer) 12/2023 - 06/2002
9	Carcinogenesis 10/2023 - 04/2008
9	Neoplasm Metastasis (Metastasis) 11/2022 - 04/2008
7	Triple Negative Breast Neoplasms 04/2024 - 06/2013
5	Neuroblastoma 05/2024 - 07/2014
5	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 04/2017
5	Carcinoma (Carcinomatosis) 01/2020 - 01/2008
2	Melanoma (Melanoma, Malignant) 10/2021 - 07/2016
2	Disease Progression 01/2021 - 12/2015
1	Hyperplasia 10/2023
1	Metabolic Diseases (Metabolic Disease) 04/2023
1	Ovarian Neoplasms (Ovarian Cancer) 11/2020
1	Multiple Myeloma 01/2019
1	Multiple Sclerosis 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016
1	Inflammation (Inflammations) 12/2015
1	Calcinosis 01/2015
1	Fibrosarcoma 01/2013
1	Ductal Carcinoma 06/2011

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2005
8	Phenobarbital (Luminal)FDA Link 12/2023 - 11/2010
7	MicroRNAs (MicroRNA)IBA 05/2024 - 01/2013
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2015
6	RNA (Ribonucleic Acid)IBA 09/2023 - 07/2014
4	Tyrosine (L-Tyrosine)FDA Link 09/2023 - 11/2010
4	Phosphotransferases (Kinase)IBA 09/2023 - 11/2010
4	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 09/2010
4	Estrogens (Estrogen)FDA Link 01/2019 - 06/2002
4	Estrogen Receptor Modulators (Antiestrogen)IBA 12/2015 - 06/2002
3	InterferonsIBA 10/2021 - 01/2013
3	Small Interfering RNA (siRNA)IBA 01/2020 - 09/2010
3	Tamoxifen FDA LinkGeneric 01/2019 - 08/2003
3	LigandsIBA 01/2018 - 06/2011
3	erucylphosphocholineIBA 12/2016 - 09/2010
2	Transcription Factors (Transcription Factor)IBA 12/2023 - 09/2010
2	ChromatinIBA 12/2023 - 01/2012
2	Vincristine (Oncovin)FDA LinkGeneric 10/2023 - 01/2022
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 09/2014
2	Estrogen ReceptorsIBA 01/2020 - 01/2012
2	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2020 - 05/2014
2	Docetaxel (Taxotere)FDA Link 01/2018 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 09/2014 - 11/2010
2	ClaudinsIBA 09/2014 - 01/2012
2	Antisense OligonucleotidesIBA 07/2014 - 06/2002
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2014 - 08/2003
2	src-Family KinasesIBA 03/2013 - 11/2010
2	Hormones (Hormone)IBA 09/2009 - 06/2002
2	Cyclin D1IBA 04/2008 - 01/2008
2	Selective Estrogen Receptor Modulators (SERM)IBA 01/2008 - 08/2003
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2024
1	Histones (Histone)IBA 12/2023
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 12/2023
1	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 10/2023
1	Antimitotic AgentsIBA 10/2023
1	EphA1 Receptor (Eph Receptor)IBA 09/2023
1	NexusIBA 04/2023
1	Immune Checkpoint InhibitorsIBA 11/2022
1	CollagenIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Small Cytoplasmic RNAIBA 10/2021
1	CD40 Ligand (CD40L)IBA 10/2021
1	ChromiumIBA 10/2021
1	Tryptophan (L-Tryptophan)FDA Link 10/2021
1	Inhibitor of Differentiation Protein 1IBA 01/2020
1	Threonine (L-Threonine)FDA Link 01/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2019
1	enzalutamideIBA 01/2019
1	Fibrillar CollagensIBA 01/2018
1	taxaneIBA 01/2018
1	cabazitaxel FDA Link 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Circulating MicroRNAIBA 04/2017
1	Conditioned Culture MediaIBA 12/2016
1	B7-H1 AntigenIBA 07/2016
1	Messenger RNA (mRNA)IBA 12/2015
1	AntibodiesIBA 12/2015
1	Diphosphonates (Bisphosphonates)IBA 01/2015
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 09/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2014
1	Long Noncoding RNAIBA 07/2014
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 07/2014
1	Inhibitor of Differentiation ProteinsIBA 05/2014
1	InterleukinsIBA 08/2013
1	Progesterone FDA LinkGeneric 06/2013
1	HhAntag691IBA 03/2013
1	Interleukin-27 (Interleukin 27)IBA 01/2013
1	CarcinogensIBA 01/2013
1	Ribonuclease III (RNase III)IBA 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Proto-Oncogene Proteins c-etsIBA 01/2012

Therapy/Procedure

19	Therapeutics 10/2023 - 01/2008
2	Immunotherapy 11/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	Castration 01/2018 - 04/2017
1	Precision Medicine 12/2023
1	Radiotherapy 12/2015